青島中程(300208.SZ):2019年度業績由盈轉虧至2.59億元
格隆匯4月15日丨青島中程(300208.SZ)披露2019年年度報告,實現營業收入7.57億元,同比下降41.76%;歸屬於上市公司股東的淨虧損2.59億元,上年同期盈利1.88億元;歸屬於上市公司股東的扣除非經常性損益的淨虧損2.58億元,上年同期盈利1.9億元;基本每股虧損0.35元。
因海外項目的設備成套業務進入後期階段,同時設備總預算成本依據項目現階段進展做出相應調整,導致該業務收入、毛利均同比下降;海外項目的施工業務產值同比下降,貢獻毛利同比降低;國際貿易與金融投資業務同比增長較大,但受制於業務的毛利較低,固實現淨利潤較少。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.